ALX Oncology Newsroom

Jefferies Downgrades ALX Oncology(ALXO.US) to Hold Rating, Cuts Target Price to $2

Futu NewsDec 21, 2024 01:32

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3

Futu NewsDec 19, 2024 18:34

ALX Oncology Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow JonesDec 18, 2024 19:44

ALX Oncology Holdings Analyst Ratings

BenzingaDec 18, 2024 19:34

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Futu NewsDec 18, 2024 05:31

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Futu NewsNov 11, 2024 20:34

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3

Futu NewsNov 8, 2024 23:31

Stifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)

TipRanksNov 8, 2024 22:41

Positive Outlook for ALX Oncology: Buy Rating Backed by Promising Clinical Data and Strong Financials

TipRanksNov 8, 2024 19:37

ALX Oncology Holdings Analyst Ratings

BenzingaAug 16, 2024 22:30

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target

BenzingaAug 13, 2024 19:20

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Futu NewsAug 13, 2024 18:31

Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept

TipRanksAug 13, 2024 18:26

ALX Oncology Holdings Analyst Ratings

BenzingaAug 12, 2024 20:37

ALX Oncology Holdings Analyst Ratings

BenzingaAug 9, 2024 20:25

ALX Oncology Price Target Cut to $5.00/Share From $14.00 by Stifel

Dow JonesAug 1, 2024 22:32

ALX Oncology Holdings Analyst Ratings

BenzingaAug 1, 2024 21:03

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target

BenzingaAug 1, 2024 21:03

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Cuts Target Price to $5

Futu NewsAug 1, 2024 20:31

Stifel Nicolaus Remains a Hold on ALX Oncology Holdings (ALXO)

TipRanksAug 1, 2024 20:15